Owkin is a French-American startup founded in 2016. As an AI-powered life science company, advancing therapeutics in several research areas such as oncology, immunology or cardiology, Owkin is building a unique platform to break research silos and engage a large community of the best medical researchers. This platform connects toptier academic medical centers and their highly curated patient datasets with state of the art privacy-preserving federated learning technologies, which permit AI model training on decentralized data at scale. Owkin also deploys AI solutions in the life science industry to help understand why drug efficacy varies from patient to patient, to enhance the drug development process and to identify the best treatment for the right patient at the right time.